AN2 Therapeutics, Inc.
ANTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001880438
In the last 90 days, AN2 Therapeutics, Inc. insiders filed 1 open-market purchase and 5 sales; 66 institutions reported holding it in 13F filings for Q2 2026, worth $119.0M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in AN2 Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- +6 vs. Q2 2023
- Shares held
- 19.9M
- +8.19M (+69.8%) vs. Q2 2023
- Total value
- $320.3M
- +$220.4M (+220.7%) vs. Q2 2023
- New holders
- 14
- 12 more added
- Sold out
- 8
- 8 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 66 | $119.0M |
| Q1 2026 | 52 | $74.8M |
| Q4 2025 | 38 | $9.88M |
| Q3 2025 | 36 | $10.5M |
| Q2 2025 | 37 | $8.78M |
| Q1 2025 | 38 | $19.5M |
| Q4 2024 | 38 | $20.1M |
| Q3 2024 | 31 | $14.5M |
| Q2 2024 | 45 | $41.7M |
| Q1 2024 | 54 | $60.9M |
| Q4 2023 | 51 | $417.9M |
| Q3 2023 | 37 | $320.3M |
| Q2 2023 | 31 | $99.9M |
| Q1 2023 | 38 | $94.8M |
| Q4 2022 | 36 | $92.9M |
| Q3 2022 | 38 | $165.1M |
| Q2 2022 | 36 | $72.4M |
| Q1 2022 | 18 | $134.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding AN2 Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 62 | $997 | 0.00% | +27+77.1% | Added |
| Federated Hermes, Inc. | 98 | $1.58K | 0.00% | +98 | New |
| Advisor Group Holdings, Inc. | 200 | $3.22K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 250 | $4.02K | 0.00% | −1,427−85.1% | Reduced |
| FMR LLC | 670 | $10.8K | 0.00% | 00.0% | Unchanged |
| Heritage Wealth Advisors | 1,060 | $17.0K | 0.00% | +1,060 | New |
| Morgan Stanley | 2,785 | $44.8K | 0.00% | −39,457−93.4% | Reduced |
| Tower Research Capital LLC (TRC) | 3,045 | $49.0K | 0.00% | +3,045 | New |
| Bank of America Corp | 3,095 | $49.8K | 0.00% | −9,121−74.7% | Reduced |
| Barclays PLC | 3,170 | $51.0K | 0.00% | −23,904−88.3% | Reduced |
| Acuta Capital Partners, LLC | 13,300 | $213.9K | 0.16% | +13,300 | New |
| State Street Corp | 15,402 | $247.7K | 0.00% | −2,700−14.9% | Reduced |
| Northern Trust Corp | 16,635 | $267.5K | 0.00% | +16,635 | New |
| Susquehanna International Group, LLP | 24,263 | $390.1K | 0.00% | +24,263 | New |
| Captrust Financial Advisors | 28,667 | $461.0K | 0.00% | +28,667 | New |
| UBS Group AG | 41,046 | $660.0K | 0.00% | −8,627−17.4% | Reduced |
| BlackRock Inc. | 42,162 | $678.0K | 0.00% | +18,680+79.6% | Added |
| RMB Capital Management, LLC | 45,942 | $738.7K | 0.03% | +45,942 | New |
| Bridgeway Capital Management, LLC | 47,500 | $763.8K | 0.02% | +20,000+72.7% | Added |
| Alyeska Investment Group, L.P. | 50,000 | $804.0K | 0.01% | −48,426−49.2% | Reduced |
| Victory Capital Management Inc | 52,100 | $837.8K | 0.00% | +52,100 | New |
| Geode Capital Management, LLC | 89,691 | $1.44M | 0.00% | +36,729+69.3% | Added |
| Monashee Investment Management LLC | 99,495 | $1.60M | 0.67% | −82,500−45.3% | Reduced |
| Citigroup Inc | 159,105 | $2.56M | 0.00% | +24,632+18.3% | Added |
| Invesco Ltd. | 187,897 | $3.02M | 0.00% | +187,897 | New |
| Nantahala Capital Management, LLC | 356,789 | $5.74M | 0.73% | +356,789 | New |
| Marshall Wace, LLP | 716,781 | $11.5M | 0.02% | +716,781 | New |
| Octagon Capital Advisors LP | 867,575 | $14.0M | 2.46% | +146,675+20.3% | Added |
| Adage Capital Partners GP, L.L.C. | 905,556 | $14.6M | 0.03% | +905,556 | New |
| Vanguard Group Inc | 939,891 | $15.1M | 0.00% | +387,092+70.0% | Added |
| Avidity Partners Management LP | 1,089,400 | $17.5M | 0.71% | +432,200+65.8% | Added |
| Janus Henderson Group PLC | 1,388,950 | $22.1M | 0.01% | +388,882+38.9% | Added |
| Frazier Life Sciences Management, L.P. | 1,388,889 | $22.3M | 1.48% | +1,388,889 | New |
| Citadel Advisors LLC | 1,556,552 | $25.0M | 0.03% | +219,569+16.4% | Added |
| BVF Inc | 1,563,963 | $25.1M | 0.68% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 2,678,209 | $43.1M | 6.34% | +1,388,889+107.7% | Added |
| Ra Capital Management, L.P. | 5,551,295 | $89.3M | 1.76% | +1,777,778+47.1% | Added |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −67,500−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −39,107−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −24,242−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −18,361−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −14,040−100.0% | Sold out |
| Integrated Wealth Concepts LLC | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −186−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −101−100.0% | Sold out |